ARCHIVES

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

Benno Schmidt, 86, Cancer Act Advocate, Chairman Of MSKCC boards, Cancer Panel

October 29, 1999

Prognostic Factors Don’t Explain Better Prostate Cancer Survival In Most Asian Men

August 31, 2007

Cancer Control Progress, Challenge Mark ACS Observance

October 18, 1991

ELM’s CHOP-DS Aims For 15% Of Patients

September 13, 1985

ACS Defends Dialogue, Calls Story “Misleading”.

October 20, 2000

Senate Bill Would Prohibit Political Appointments To Advisory Groups

January 9, 1976